0001246360-12-004368.txt : 20121109 0001246360-12-004368.hdr.sgml : 20121109 20121109091511 ACCESSION NUMBER: 0001246360-12-004368 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121030 FILED AS OF DATE: 20121109 DATE AS OF CHANGE: 20121109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Glynn Michael CENTRAL INDEX KEY: 0001528924 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23155 FILM NUMBER: 121191881 MAIL ADDRESS: STREET 1: 1380 WILLOW ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNAGEVA BIOPHARMA CORP CENTRAL INDEX KEY: 0000911326 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 561808663 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SPRING STREET STREET 2: SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: (781) 357-9900 MAIL ADDRESS: STREET 1: 128 SPRING STREET STREET 2: SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: TRIMERIS INC DATE OF NAME CHANGE: 19970516 3 1 form.xml PRIMARY DOCUMENT X0206 3 2012-10-30 0 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001528924 Glynn Michael 128 SPRING STREET, SUITE 520 LEXINGTON MA 02421 false true false false SVP Global Business Operations Stock Option (Right to Buy) 57.56 2022-10-04 Common Stock 40000 D The stock option granted the reporting person is an option to purchase 40,000 shares of the issuer's common stock ("Shares"). 25% of such Shares vest and become exercisable on 09/03/2013, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter. Michael J. Glynn 2012-11-09